Utah Medical Products, Inc.
UTMD
$63.12
$0.250.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.58% | -26.16% | -11.73% | -23.13% | -32.29% |
| Total Depreciation and Amortization | 4.11% | 3.92% | 9.38% | 5.56% | -29.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.13% | -- | 41.12% | -21.43% | 139.23% |
| Change in Net Operating Assets | 110.39% | 158.84% | 31.87% | 11.88% | -340.00% |
| Cash from Operations | 18.39% | 0.57% | 4.02% | -15.39% | -44.92% |
| Capital Expenditure | -1,111.11% | 69.66% | 53.64% | -736.36% | 90.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,111.11% | 69.66% | 55.65% | -3,780.00% | 90.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 85.18% | 83.11% | 45.54% | -7.73% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 5.88% | 6.08% | 7.40% | 6.61% | 3.08% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 74.56% | 66.63% | 37.58% | -6.40% | -623.34% |
| Foreign Exchange rate Adjustments | 114.00% | -131.77% | 1,230.43% | 185.75% | -234.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 127.19% | 372.23% | 75.03% | -62.87% | -217.54% |